论文部分内容阅读
肿瘤病人的预后与肿瘤分期和机体免疫功能关系密切。可溶性白细胞介素2受体(slL-2R)是近年来发现的一种重要的免疫抑制因子,与IL-2介导的免疫反应密切相关,我们对围手术期血清slL-2R水平变化及与预后的关系进行了临床动态研究。现报告如下。 1 材料与方法临床资料:①肿瘤组1993年1～3月间因腹部恶性肿瘤行根治手术的病人44例,男24例,女20例,年龄27～80岁,平均58.4岁。肿瘤部位见表1,其中肝胆胰癌包括原发性肝癌4例(均在1年内死亡)、壶腹部癌3例、肝管癌2例和胰腺癌2例。根据病理结果
The prognosis of tumor patients is closely related to tumor stage and immune function. Soluble interleukin 2 receptor (slL-2R) is an important immunosuppressive factor discovered in recent years. It is closely related to the immune response mediated by IL-2. Our serum levels of slL-2R and its changes The relationship between prognosis and clinical dynamics was studied. The report is as follows. 1 Materials and methods Clinical data: 1 In the tumor group, 44 patients underwent radical surgery for abdominal malignancy between January and March 1993. There were 24 males and 20 females, aged 27 to 80 years, with an average age of 58.4 years. The tumor sites are shown in Table 1. Hepatobiliary and pancreatic cancers included 4 cases of primary liver cancer (all died within 1 year), 3 cases of ampullary carcinoma, 2 cases of hepatic duct cancer, and 2 cases of pancreatic cancer. According to pathological results